gimli
AAREYDRUGS stock analysis context
AAREY DRUGS & PHARM Stock Context for AI Screening
AAREY DRUGS & PHARM LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for AAREY DRUGS & PHARM, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive AAREYDRUGS stock pagePrice
₹76.76
1W return
-3.74%
1M return
-15.72%
3M return
+10.18%
6M return
-0.78%
1Y return
+45.90%
Market cap
₹217.65 cr
PE
63.45
PB
1.46
ROE
n/a
ROCE
n/a
RSI
39.00
Turnover
₹0.96 cr
Why it can matter in screens
- Momentum: AAREYDRUGS is above 200DMA; RSI is 39.00.
- Returns: 1D +1.53%, 1W -3.74%, 1M -15.72%, 3M +10.18%, 1Y +45.90%.
- Trend levels: 52W high ₹99.25, 52W low ₹50.16, off high -22.66%.
- Liquidity: latest turnover is ₹0.96 cr; volume vs 20D is +1.97%.
- Valuation/profitability: PE 63.45, PB 1.46, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-12-31 | 96.43 cr | 2.67 cr | 0.57 cr | 0.20 |
| 2025-09-30 | 84.16 cr | 3.44 cr | 1.02 cr | 0.36 |
| 2025-06-30 | 102.21 cr | 3.25 cr | 1.37 cr | 0.48 |
| 2025-03-31 | 106.39 cr | 2.55 cr | 0.47 cr | nan |
| 2024-12-31 | 133.79 cr | 2.88 cr | 0.72 cr | 0.26 |
| 2024-09-30 | n/a | n/a | n/a | 0.57 |
Annual income statement
No recent data available.
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-09-30 | 294.00 cr | 7.19 cr | 50.78 cr | 148.85 cr |
| 2025-03-31 | 290.59 cr | 1.47 cr | 34.86 cr | 138.48 cr |
| 2024-09-30 | 274.53 cr | 1.49 cr | 38.65 cr | 135.59 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-12-31 | n/a | n/a | n/a |
| 2025-09-30 | n/a | n/a | n/a |
| 2025-06-30 | n/a | n/a | n/a |
| 2025-03-31 | n/a | n/a | n/a |
| 2024-12-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +37.71% | +4.18% | +1.62% | +0.00% | +56.49% | +0.00% |
| 2025-12-31 | +39.06% | +3.86% | +0.00% | +0.00% | +57.09% | +0.00% |
| 2025-09-30 | +44.80% | +1.13% | +0.00% | +0.00% | +54.07% | +100.00% |
| 2025-06-30 | +44.80% | +1.97% | +0.00% | +0.00% | +53.23% | +100.00% |
| 2025-03-31 | +44.80% | +2.34% | +0.00% | +0.00% | +52.86% | +100.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 429,121.06 cr | 40.824543 | +15.06% | +7.26% |
| DIVISLAB | DIVI S LABORATORIES LTD | 174,585.42 cr | 68.707369 | +17.81% | +0.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 147,849.87 cr | 68.354079 | +29.94% | +39.35% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 119,204.71 cr | 64.295958 | +23.21% | +21.70% |
| CIPLA | CIPLA LTD | 111,088.72 cr | 29.624450 | +12.91% | -6.65% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 108,331.15 cr | 21.874917 | +20.44% | +16.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 105,181.70 cr | 24.542479 | +13.88% | +1.20% |
| LUPIN | LUPIN LIMITED | 103,385.66 cr | 22.341869 | +29.22% | +15.72% |
Try these prompts
- Analyze AAREY DRUGS & PHARM with valuation, momentum and industry peers
- Compare AAREYDRUGS with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare AAREYDRUGS with other Healthcare stocks
Data snapshot: 2026-06-03. Not investment advice.